Accord Challenges Novartis Blood Pressure Patent At Trial
Accord told a London court Monday that protections for Novartis' blood pressure medication should be revoked, arguing that the patent does not pass the required legal tests....To view the full article, register now.
Already a subscriber? Click here to view full article